Basic Search
|
Geographic Searches
|
Advanced Search |
MegadealsSubsidy Tracker: Industry Summary Page
Major Industry: pharmaceuticals
Subsidy Total: $3,972,211,621
Number of Awards: 2,783
Time Period: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2012.
Notes: The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.
Top 10 Parent Companies | Total Subsidy $ | Number of Awards |
Eli Lilly | $601,741,368 | 77 |
Regeneron Pharmaceuticals | $469,433,071 | 112 |
AstraZeneca | $436,175,713 | 52 |
Pfizer | $332,313,011 | 206 |
Novo Holdings A/S | $241,475,902 | 102 |
Elanco Animal Health | $189,545,200 | 7 |
Merck | $153,889,367 | 82 |
AbbVie | $145,729,008 | 68 |
Johnson & Johnson | $111,279,431 | 124 |
Bristol-Myers Squibb | $110,616,473 | 81 |
Individual Subsidy Records:
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
Liquent, Inc. | Parexel International | Pennsylvania | state | 2017 | $65,812 | | tax credit/rebate |
PAREXEL International, LLC | Parexel International | North Carolina | state | 2019 | $4,194,000 | | grant |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2011 | $209,316 | | training reimbursement |
Otsuka America Pharmaceutical, Inc. & Otsuka | Otsuka Pharmaceutical | New Jersey | state | 2009 | $1,449,375 | | grant |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |
Otsuka America Inc. | Otsuka Pharmaceutical | Maryland | state | 2010 | $65,321 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2011 | $60,998 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2005 | $195,386 | | tax credit/rebate |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2008 | $96,916 | | tax credit/rebate |
Otsuka American Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2007 | $92,420 | | tax credit/rebate |
Otsuka America, Inc. c/o Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | Maryland | state | 2009 | $65,411 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2012 | $59,756 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2004 | $47,393 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2014 | $59,756 | | tax credit/rebate |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2015 | $91,536 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2016 | $63,252 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2017 | $58,747 | | tax credit/rebate |
AVANIR PHARMACEUTICALS INC | Otsuka Pharmaceutical | California | state | 2017 | $12,225 | | training reimbursement |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2018 | $68,671 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2019 | $26,526 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2020 | $26,857 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Ohio | state | 2022 | $2,080,000 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2011 | $42,682 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2006 | $68,653 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2008 | $25,745 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2009 | $25,745 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2010 | $25,745 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2012 | $44,191 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2013 | $44,191 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2014 | $398,897 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2015 | $398,897 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2016 | $309,936 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2017 | $2,436,956 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2018 | $2,479,491 | | tax credit/rebate |
OMEROS CORPORATION | Omeros Corp. | Washington | state | 2019 | $2,138,039 | | tax credit/rebate |
Omeros Corporation | Omeros Corp. | Washington | state | 2020 | $2,125,967 | | tax credit/rebate |
Omeros Corporation | Omeros Corp. | Washington | state | 2021 | $2,125,967 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals | Novo Holdings A/S | North Carolina | state | 2008 | $746,648 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $718,878 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $429,500 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $372,272 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $270,783 | | tax credit/rebate |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2004 | $1,120,000 | | grant |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2010 | $3,032,000 | | grant |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $1,375,593 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $196,973 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | New Jersey | state | 2007 | $420,000 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | New Jersey | state | 2007 | $1,387,680 | | Tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2009 | $48,215 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2010 | $46,571 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2009 | $53,997 | | tax credit/rebate |
Novozymes Biologicals, Inc. | Novo Holdings A/S | Virginia | state | 2010 | $44,312 | | training reimbursement |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $649,364 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $214,710 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2011 | $93,540 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2010 | $105,430 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $78,340 | | tax credit/rebate |